STOK · Stoke Therapeutics, Inc.
$29.05
-0.06 (-0.21%)
At close · Jul 17
Market Cap
$1.81B
Shares
62,281,655
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ian F. Smith | CEO | $27,031,655 |
| Edward M. Kaye | CEO | $3,234,043 |
| Jason Hoitt | Chief Patient Officer | $2,269,955 |
| Thomas E. Leggett | CFO | $1,830,375 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Edward M. Kaye | CEO | $5,612,120 |
| Thomas E. Leggett | CFO | $4,520,386 |
| Barry S. Ticho | Chief Medical Officer | $2,469,437 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Edward M. Kaye | CEO | $3,533,210 |
| Barry S. Ticho | Chief Medical Officer | $1,648,007 |
| Stephen J. Tulipano | CFO | $1,598,481 |
| Thomas E. Leggett | CFO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Edward M. Kaye | CEO | $5,748,522 |
| Barry S. Ticho | Chief Medical Officer | $2,386,257 |
| Stephen J. Tulipano | CFO | $2,316,523 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Edward M. Kaye | CEO | $8,543,358 |
| Barry S. Ticho | Chief Medical Officer | $3,149,491 |
| Stephen J. Tulipano | CFO | $3,101,566 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Barry S. Ticho | Chief Medical Officer | $1,877,496 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Robin A. Walker | Senior Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary | $1,241,542 |
| Stephen J. Tulipano | CFO | $1,176,396 |
Key facts
CIK
1623526
CUSIP
86150R107
13F (30d)
10 filings
10 filers
Visit website
Investor relations